» Articles » PMID: 22737267

Maspin Reprograms the Gene Expression Profile of Prostate Carcinoma Cells for Differentiation

Abstract

Maspin is an epithelial-specific tumor suppressor gene. Previous data suggest that maspin expression may redirect poorly differentiated tumor cells to better differentiated phenotypes. Further, maspin is the first and only endogenous polypeptide inhibitor of histone deacetylase 1 (HDAC1) identified thus far. In the current study, to address what central program of tumor cell redifferentiation is regulated by maspin and how tumor microenvironments further define the effects of maspin, we conducted a systematic and extensive comparison of prostate tumor cells grown in 2-dimensional culture, in 3-dimensional collagen I culture, and as in vivo bone tumors. We showed that maspin was sufficient to drive prostate tumor cells through a spectrum of temporally and spatially polarized cellular processes of redifferentiation, a reversal of epithelial-to-mesenchymal transition (EMT). Genes commonly regulated by maspin were a small subset of HDAC target genes that are closely associated with epithelial differentiation and TGFβ signaling. These results suggest that a specific endogenous HDAC inhibitor may regulate one functionally related subset of HDAC target genes, although additional maspin-induced changes of gene expression may result from tumor interaction with its specific microenvironments. Currently, EMT is recognized as a critical step in tumor progression. To this end, our current study uncovered a link between maspin and a specific mechanism of prostate epithelial differentiation that can reverse EMT.

Citing Articles

Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects.

Tang S, Ling Z, Jiang J, Gu X, Leng Y, Wei C Front Oncol. 2022; 12:1037794.

PMID: 36523976 PMC: 9745138. DOI: 10.3389/fonc.2022.1037794.


The vulnerable primed cancer stem cells in disguise: demystifying the role of Maspin.

Sheng S, Bernardo M, Dzinic S, Chen K, Sakr W Cancer Metastasis Rev. 2022; 41(4):965-974.

PMID: 36451067 PMC: 9713111. DOI: 10.1007/s10555-022-10070-2.


Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells.

Tang S, Lian X, Cheng H, Guo J, Ni D, Huang C J Inflamm Res. 2021; 14:5849-5862.

PMID: 34785925 PMC: 8590462. DOI: 10.2147/JIR.S332943.


Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.

Lin Y, Tsui K, Chang K, Hou C, Feng T, Juang H Cancers (Basel). 2019; 12(1).

PMID: 31861435 PMC: 7016534. DOI: 10.3390/cancers12010010.


Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.

Dzinic S, Mahdi Z, Bernardo M, Vranic S, Beydoun H, Nahra N PLoS One. 2019; 14(4):e0215089.

PMID: 31002675 PMC: 6474598. DOI: 10.1371/journal.pone.0215089.


References
1.
Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T . Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol. 2008; 33(1):17-24. View

2.
Sharma S, Lee D, Li B, Quinlan M, Takahashi F, Maheswaran S . A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 2010; 141(1):69-80. PMC: 2851638. DOI: 10.1016/j.cell.2010.02.027. View

3.
Zou Z, Anisowicz A, Hendrix M, Thor A, Neveu M, Sheng S . Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994; 263(5146):526-9. DOI: 10.1126/science.8290962. View

4.
Zhang M, Maass N, Magit D, Sager R . Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ. 1997; 8(2):179-86. View

5.
Lei W, Zhang K, Pan X, Hu Y, Wang D, Yuan X . Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition. Int J Biochem Cell Biol. 2010; 42(9):1489-97. DOI: 10.1016/j.biocel.2010.05.006. View